HomeDealsNegotiationsPolicyPipelineMoneyPeopleDataThe WeekPharmTech 100CompaniesDeal TrackerResearch
Biotech

Genentech, Inc.

1
Articles
Deal Party
Top Role
Jan 19, 2026
First Mention
Jan 19, 2026
Last Mention
1.2
Relevance Score

Coverage Timeline

January 2026
The Economics of Pharma Mega-Mergers: Why Most Buyers Overpay Deals Deal Party
Jan 19, 2026
Roche’s $46.8 billion buyout of Genentech stands out, a rare example in which a sky-high multiple actually bought world-class R&D and decades of pipeline leadership.
Related Companies
Medivation, Inc.
1 shared
Hospira, Inc.
1 shared
Genzyme Corporation
1 shared
Sanofi S.A.
1 shared
Roche Holding AG
1 shared
Bristol Myers Squibb Company
1 shared
Pfizer Inc.
1 shared
Allergan plc
1 shared
AbbVie Inc.
1 shared